Providence First Trust Co purchased a new position in Lam Research Corporation (NASDAQ:LRCX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,507 shares of the semiconductor company’s stock, valued at approximately $943,000.
Several other hedge funds and other institutional investors have also made changes to their positions in LRCX. Vanguard Group Inc. boosted its stake in Lam Research by 0.3% during the third quarter. Vanguard Group Inc. now owns 130,974,214 shares of the semiconductor company’s stock valued at $17,537,447,000 after buying an additional 364,949 shares during the last quarter. State Street Corp raised its stake in shares of Lam Research by 0.4% during the 3rd quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company’s stock worth $8,024,684,000 after acquiring an additional 265,805 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Lam Research by 18.2% during the 3rd quarter. Invesco Ltd. now owns 21,182,948 shares of the semiconductor company’s stock valued at $2,836,397,000 after purchasing an additional 3,263,658 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Lam Research by 781.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock worth $1,518,542,000 after acquiring an additional 10,053,978 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in Lam Research by 6.8% during the 3rd quarter. Nordea Investment Management AB now owns 11,312,752 shares of the semiconductor company’s stock valued at $1,512,854,000 after purchasing an additional 718,178 shares in the last quarter. Institutional investors own 84.61% of the company’s stock.
Insider Activity
In other news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. This trade represents a 12.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Neil J. Fernandes sold 18,170 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $255.14, for a total transaction of $4,635,893.80. Following the sale, the senior vice president directly owned 66,129 shares in the company, valued at approximately $16,872,153.06. The trade was a 21.55% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 155,066 shares of company stock valued at $35,849,242. 0.31% of the stock is currently owned by company insiders.
Lam Research Stock Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, beating the consensus estimate of $1.36 by $0.11. The company had revenue of $5.84 billion during the quarter, compared to analysts’ expectations of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The firm’s revenue was up 23.8% compared to the same quarter last year. During the same quarter last year, the company posted $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, analysts anticipate that Lam Research Corporation will post 5.68 EPS for the current year.
Wall Street Analysts Forecast Growth
LRCX has been the topic of a number of research reports. Oppenheimer reissued an “outperform” rating and issued a $330.00 price objective on shares of Lam Research in a report on Thursday, April 23rd. Needham & Company LLC reiterated a “buy” rating and set a $300.00 target price on shares of Lam Research in a research report on Thursday, April 23rd. Evercore lifted their price objective on Lam Research from $275.00 to $300.00 and gave the stock an “outperform” rating in a report on Thursday, April 23rd. Sanford C. Bernstein lifted their target price on shares of Lam Research from $285.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, April 23rd. Finally, New Street Research lifted their price target on shares of Lam Research from $235.00 to $280.00 and gave the company a “neutral” rating in a research report on Monday, April 27th. Twenty-six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $285.94.
Check Out Our Latest Stock Report on Lam Research
Lam Research News Roundup
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Earnings beat + bullish near?term guide — Lam reported a March?quarter revenue and EPS beat and gave an upbeat June?quarter outlook, which the market interpreted as accelerating wafer?fab demand and margin expansion. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
- Positive Sentiment: TAM and secular demand lift the investment case — Analysts and commentators raised WFE and hyperscaler?capex forecasts (Lam’s environment looks larger), reinforcing growth expectations and the claim that AI-driven device complexity benefits Lam’s etch/deposition exposure. Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising — BUY
- Positive Sentiment: Analyst target upgrades and bullish notes — Multiple firms have raised price targets and reiterated Outperform/Buy calls after the quarter, supporting momentum and upside thesis. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
- Positive Sentiment: Technical breakout / IBD recognition — The stock cleared an IBD buy point after the strong report, drawing momentum and retail/institutional interest. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
- Neutral Sentiment: Insider sale disclosed — An SVP sold ~18k shares under a pre?arranged Rule 10b5?1 plan; routine disclosure but worth noting for timing/context. Insider Selling: Lam Research (NASDAQ:LRCX) SVP Sells 18,170 Shares of Stock
- Neutral Sentiment: Valuation and “froth” commentary — Some analysis flags stretched multiples and consolidation risk after the run; elevated P/E requires investors to weigh growth vs. premium valuation. Lam Research Is Approaching Frothy Levels
- Negative Sentiment: Insider and institutional selling activity — Reports show multiple executive sales and notable institutional repositioning in recent quarters; while some are pre?planned or rebalancing, sustained selling can temper sentiment if it continues. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Articles
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
